The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 

Asthma Adherence - A Guide for Health Professionals

Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Asthma Adherence

Foreword
Preface
Introduction
Section I
Section II
Section III
Questionnaire
Behaviour Change
References
Tips
Content updated Jun 2001
Page updated 23 Jun 2005

Get Adobe Reader

Get Adobe Flash Player

Section II - Influences on Adherence

By now, it should be clear that there are many factors that influence a patient's level of adherence. Adherence should always be evaluated within a context, taking into account the behavioural and environmental factors which impact on adherence.

The literature shows evidence for the following factors affecting adherence:

Regimen on Complexity

Put simply:

  • The more medications prescribed, the less likely they are to be taken. One study measuring compliance with inhaled medication in asthma showed that as medication dosing became more frequent the adherence decreased from 71% twice a day to 18% four times a day (Coutts, Gibson & Paton 1994).
  • The more frequent the dose, the less likely it is to be taken.
  • The greater the interference with lifestyle, the less likely the patient is to adhere.

Readability of Materials

The data about readability of information and instruction leaflets indicates that many are too difficult for patients to understand. This has obvious implications for adherence (Smith et al. 1998). It is important to be mindful of a patient's level of education, cultural background, and literacy skills when providing information.

Most people with asthma use their medication as prescribed when they are symptomatic, as there is an immediate connection between taking medication and the relief of symptoms. For the same reason, adherence with reliever medication tends to be greater than adherence with preventive medication. Once symptoms resolve, continued adherence becomes increasingly difficult for many people with asthma (National Asthma Campaign 1998).

The Patient's Health Beliefs

People bring into the consultation their own beliefs and perceptions about the illness. A study found that exploring these beliefs about the illness and the benefits and barriers to taking medication and working with the patient to come up with some sort of solution, led to better patient outcomes (Janz & Becker 1984; Innui, Yourtee & Williamson 1976; Cockburn 1997).

 

There is some evidence that compliance decreases when the frequency of dose increases. There is, however, no convincing evidence of an important difference in compliance levels between one and twice daily dosing. Pullar (1998) concluded that, '...compliance with the once-daily regimen was best, but...compliance with a twice-daily regimen was very similar and both are superior to doing three times a day'.
 

A number of studies describe marked differences between the beliefs of patients and doctors about diagnosis and treatment. The patient's so-called 'unorthodox' (i.e., different from the current bio-medical) beliefs may well be unvoiced in the course of an otherwise unremarkable consultation. It is thought that these may be significant predictors of non-adherence (Britten 1996).

Attitudes to Medications

Communication and open-ended questioning are useful tools to discover a patient's attitudes to medications and medicine-taking, which will certainly influence their adherence to treatment. Sociological literature identifies the following attitudes to medications in many patients:
 

  • the danger of becoming 'immune' over time
  • the 'unnaturalness' of manufactured medicines
  • the danger of addiction and dependence
  • an 'anti-drug' attitude

(Royal Pharmaceutical Society 1997).


An Australian study suggested that in some circumstances, non-adherence can be seen as an active attempt by the patient to reduce medication use. This has been termed 'intelligent non-adherence' because of the process through which the patient is trying to do what the doctor does, which is to manage asthma with the lowest dose of drug possible (Toelle 1998).

Always provide an opportunity for patients to express any concerns about the medication. Unvoiced concerns about continued drug use are a prime reason for discontinuing appropriate self-management. Give a balanced explanation of the benefits/risks of the medications.

The Quality of Interactions between Health Professionals and Patients

The quality of interactions between doctor and patient can have a major influence on health outcomes (Kaplan 1989; Toelle, Peat & Dunn 1998).

As stated, communication and partnership, combined with flexible, non-judgmental and pragmatic attitude, lead to improved patient outcomes in terms of adherence.

Psychological Factors

There is an emerging field of research which has identified psychosocial factors as particularly important influences on adherence, and a risk factor for asthma death (Rea et al. 1986). Broadly defined, these factors could be psychiatric illness, drug abuse, intellectual handicap, denial of asthma severity or social isolation. Psychosocial factors were found to have contributed to the asthma episode in 86% of asthma deaths and 88% of cases of near-fatal asthma (Campbell et al. 1992). Diabetes literature supports the importance of psychosocial factors in adherence. There is evidence that having a supportive family is associated with better self-management in adolescence (Evans 1993). Adherence is also affected by the patient's physical or social vulnerability (for example, being old, belonging to an ethnic minority, suffering from a psychiatric illness) (Royal Pharmaceutical Society 1997).

International research has also identified elements which are not good predictors of adherence. There is a weak correlation between the following demographics and the way in which medication is taken:

  • age
  • sex
  • socioeconomic status
  • severity of disease
  • disease-specific knowledge

(Royal Pharmaceutical Society 1997).

Nevertheless it is clear that these factors and issues or factors should still be taken into account when assessing a patient's adherence to treatment, or devising a management plan. For example, here are some thoughts about the influence of a patient's age on their capacity/willingness to adhere to treatment:

 

'...the best drug in the world is only as good as it is able to be correctly used. (Sawyer 1998)

 

Barriers to adherence by children are compounded by their dependence on parents (or carers) for the provision and often administration of their therapy. Communication with the parent or carer is important so that you can elicit their concept of asthma, which has a powerful effect on therapy and adherence. This concept will be influenced by the parent's own experience of asthma, and their experience with family members or friends. For children, the functional status of the family plays a major role in influencing adherence, for example, the number of children in the family, the number of parents administering medication, issues of time management.

 

 

'...there are still many issues of peer pressure for many children - avoiding the use of preventive medication at school can help to ease this barrier.  There should be regular reviews to update children with asthma.  It is important not only that the child has an age-appropriate delivery device, but as they get older that they can actually contribute to the decision about delivery devices used.'

(Robertson 1997)

 

Young people develop increasing independence during adolescence and want greater autonomy and control. They continue to require a variable level of supervision and support from parents. The growing influence of peers and the values they espouse has great significance during adolescence.  For some young people, the presence of asthma and the requirement for regular medication acts as a barrier to participation in peer activities. For others, the importance of establishing a regular routine for medication has greater salience for adherence.

Young people can experience a conflict of priorities when it relates to asthma management, such as the need to be socially acceptable to peers versus the requirement to take regular medication. The influences on young people's behaviours may not be obvious. For example, some young women are too embarrassed to use their inhaler in front of boys because of its phallic shape (Morsch, Stewart & Roller 1996). Clearly, gaining an understanding of the young person's perspective, values and aspirations is a key goal for health professionals if they are to influence health promoting behaviours.  While striving for the best health outcomes, health professionals should aim for pragmatism not perfection (Bowes 1997).

 

 

'Many young people with asthma are employed part-time in pubs or the entertainment area which exposes them to cigarette smoke in their work environment. Having a job is often more important to them than avoiding environments which can exacerbate their asthma.'

(Bowes 1997)

 

Older people also have many unique factors influencing their adherence. Some studies have indicated that 25-50% of particular groups of elderly patients do not, or cannot, take all their medications as prescribed (Shimp 1985). Older people are more susceptible to adverse reactions to medications, which discourage adherence (Williamson 1980). The issue of drug interactions can also increase the incidence of fear amongst the elderly about the amount of medication they take. Also, 20% of those over 85 years of age have poor vision. Other factors to take into account include: strength and motor coordination; cognition (the incidence of dementia is expected to go up vastly over the next 20 years); depression and isolation. Older people also tend to under-report their symptoms. The presence of other diseases (such as heart disease) makes asthma symptoms more difficult to identify (Yates 1997).

The following factors do not have the same level of concrete evidence from the literature as proven influences on adherence, but are still important considerations

Social and Cultural Factors

One study found that people who had better family communication were more likely to follow advice; we all know that family support is important. There is some level of evidence from the psychiatric literature that by actively soliciting family support, people might be more likely to adhere (Zhang et al. 1994).

Doctor/Patient Communication

Goldberg (1983) found that when doctors used strategies such as open-ended questions at the beginning of the consultation, showing empathy and warmth and following up on verbal cues, it resulted in more accurate diagnoses. Consultation styles do lead to more accurate detection and assessment of non-adherence (Cockburn 1997).

Theories of Behaviour Change

Healthy behaviour can be seen as a means of achieving higher priorities, or it can be seen as a constraint.

Adherence is not a high priority for most patients. Most people are simply interested in getting on with what they want to do in life, and hopefully not having their asthma interfere with their ability to do that. One study of people with epilepsy (Conrad 1985) showed that patients' medication-taking behaviours were more influenced by events in their daily routine than by their doctors' advice. If poor adherence works for them, why should they change? The disruption to routine, or reduced spontaneity that comes with some treatment regimens may be seen as too great a cost for some patients, especially if the patient does not identify any real benefits from adherence.

 

Behaviour Change cartoon

 

 

'Doin' stuff'

'The Ziggy Principle was formulated by Bob Kaplan (1994). Ziggy is an American cartoon character: to Ziggy the meaning of life is 'doing stuff'. For most people, the Ziggy Principle informs the way they feel about their lives: doing stuff, or our capacity to do things and behave, is more important than our medical 'health status'. For most of us, most of the time, health is a fairly low priority. We see it as a means to an end so we can do all the stuff that we want to be able to do. People are usually trained to optimise their life outcomes, and most people in the health field are focusing on trying to optimise health outcomes. It is worth keeping in mind that the two are not necessarily the same and that your goals may not match those of your patient.'

(Borland 1997)

 

Models of individual behaviour change in psychology tend to focus around what are known as expectancy value models, which an economist would call a cost benefit analysis. Basically, it is a cognitive appraisal by the patient - what's in it for me? - looking at the barriers of the costs, and comparing them with the perceived benefits. For example, in terms of taking medication, a child may perceive the benefit of earning the praise of her mother, but also be wary that her friends at school will laugh at her if she takes her medication, acting as a barrier.

Most models argue that our beliefs lead to our behaviour. Many health professionals also know that behaviour changes can also work on a patient's initially negative attitude: 'Just try it a couple of times, and see how it goes …' We need to find a way to get patients to change their behaviour, by convincing them that the benefits of adherence outweigh the costs, and devising practical strategies so that the treatment plan fits in as neatly as possible with the patient's lifestyle and aspirations.

Patient Attitudes

A qualitative study from Canada explored patients' experiences of asthma. It found that initially patients identified two key feelings: loss of control and fear. The process of overcoming these feelings and moving to acceptance and having the asthma controlled, rather than being controlled by the asthma, came through knowledge, self awareness and experience, facilitated by a mentor (Snadden & Brown 1992).

Personal Risk Management Strategies

There is some evidence that patients themselves attempt to analyse their positive and negative perceptions about the medicine and carry out their own cost-benefit analyses (Donovan 1992). This may then manifest as poor adherence.